Healthcare Triangle Schedule 13G: Orca Capital 7.4% Stake

Rhea-AI Filing Summary

Healthcare Triangle, Inc. Schedule 13G shows Orca Capital beneficially owns 86,058 shares of Common Stock, representing 7.4% of the class as reported immediately after the issuer's registered offering and tied to an aggregate outstanding count of 1,155,370 shares described in the prospectus supplement. The filing lists sole voting and dispositive power over 86,058 shares and is signed by Thomas Konig on 03/02/2026.

Insights

Equity Ownership Analyst

Orca Capital holds a notable 7.4% stake in Healthcare Triangle.

The filing states 86,058 shares beneficially owned with sole voting and dispositive power, anchored to an outstanding base of 1,155,370 shares noted in the prospectus supplement. The percentage is calculated "immediately after" the issuer's registered offering.

Holder intentions and trading plans are not disclosed here; subsequent disclosures or Form 4s would show changes if transactions occur.

Corporate Governance Specialist

Ownership disclosure clarifies control and voting authority but does not indicate transactions.

The Schedule 13G records sole voting and dispositive power for Orca Capital over 86,058 shares, which equates to 7.4% of the class per the filing's math. The filing is signed by an authorized signatory.

Because this is a passive ownership schedule, it is a disclosure of stake rather than a corporate action; governance implications depend on any future filings or shareholder coordination.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of HCTI does Orca Capital report owning?

Orca Capital reports beneficial ownership of 86,058 shares. This represents 7.4% of the class, calculated using an outstanding share base of 1,155,370 shares referenced in the issuer's prospectus supplement.

What voting and disposition powers does Orca Capital have in HCTI?

The filing states Orca Capital has sole voting and sole dispositive power over 86,058 shares. The Schedule lists zero shared voting or dispositive power for these holdings.

What date is associated with Healthcare Triangle's ownership disclosure?

The Schedule 13G includes an ownership calculation tied to the issuer's prospectus supplement and is signed on 03/02/2026. The ownership reference date in the header is 02/26/2026.

Does this Schedule 13G show Orca Capital is an activist or a passive holder?

The filing is a Schedule 13G disclosure of beneficial ownership rather than an explicit activism statement. It reports a 7.4% stake and lists sole powers but does not state any activist intentions or plans.

How was the 7.4% ownership percentage calculated for HCTI?

The percentage is calculated using an aggregate outstanding figure of 1,155,370 shares referenced as "immediately after" the issuer's registered offering in the prospectus supplement filed February 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:30 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Healthcare Triangle, Inc.

(Name of Issuer)

Common Stock, par value $0.00001 per share

(Title of Class of Securities)

02/26/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Orca Capital AG

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 86,058.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 86,058.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

86,058.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.4 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 1,155,370 shares of Common Stock outstanding immediately after giving effect to the completion of the Issuer's registered offering as provided in the Issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on February 27, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Healthcare Triangle, Inc.
(b)	Address of issuer's principal executive offices: 7901 Stoneridge Drive, Suite 210, Pleasanton, CA 94588
Item 2.
(a)	Name of person filing: Orca Capital AG
(b)	Address or principal business office or, if none, residence: Sperlring 2 85276 Hettenshausen Deutschland
(c)	Citizenship: Germany
(d)	Title of class of securities: Common Stock, par value $0.00001 per share
(e)	CUSIP No.: 42227W405
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 86,058
(b)	Percent of class: 7.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 86,058
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 86,058
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Orca Capital AG

Signature:	/s/ Thomas Konig
Name/Title:	Thomas Konig/Director
Date:	03/02/2026